GVR Report cover Transplant Diagnostics Market Size, Share & Trends Report

Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology (Molecular Assays, Non-Molecular Assays), By Product (Reagents & Consumables, Instruments), And Segment Forecasts, 2018 - 2024

  • Report ID: 978-1-68038-970-8
  • Number of Pages: 76
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2015
  • Industry: Healthcare

Industry Insights

The global transplant diagnostics market size was valued at USD 500.1 million in 2016 and is likely to expand at a CAGR of 7.6% over the forecast period. Increasing organ transplants is a major factor driving demand for diagnostics used before the procedure. The demand for transplants has always been higher than the supply of organs. However, extensive research and analysis in the field to bridge this gap is likely to benefit the market.

U.S. transplant diagnostics market

Initiatives by the European Commission for organ harvesting have resulted in the availability of donated organs. The availability of the European donor card and increasing awareness among people have also augmented the organ donation rate in the region. Similarly, the U.S. has experienced considerable growth in organ donations due to rising awareness.

In addition, an increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. Moreover, the adoption of stem cell therapy and personalized medicine is escalating. As a result, demand for pre-procedure diagnostics is growing swiftly. Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools.

Next Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to demand for high-throughput diagnostic tools with enhanced accuracy.

Technology Insights

These pre-transplantation analysis techniques are employed to ensure safe and effective procedures. Factors such as growing awareness among physicians and the rapid adoption of technologically advanced tools are expected to drive growth in the future.

Molecular assays are preferred by physicians as compared to non-molecular assays. In addition, there has been a gradual shift in preference from serological assays to HLA typing owing to its benefits such as accuracy, efficacy, and lower risk. Currently, the PCR-based assay segment holds the largest market share owing to multiple applications.

The sequencing-based assay segment is expected to be the fastest-growing segment during the forecast period. The market growth may have a negative impact due to factors such as strict regulatory protocols, slower approval processes, poor reimbursement policies for organ transplants, and social and ethical controversies in different parts of the world.

Products Insights

Based on product, the transplant diagnostics market is segmented into reagents and consumables, instruments, and services and software. Manufacturers of these type of diagnostic products are adopting strategies such as purchase contracts for reagents and consumables. In addition, the key factor accelerating the adoption of reagents and consumables is their repeat purchase. As a result, the segment accounted for the largest revenue share in 2016 and is expected to retain its dominance during the forecast period.

Global transplant diagnostics market

The services and software segment is expected to follow reagents and consumables in terms of growth. The growth of this segment can be attributed to rise in the introduction of sophisticated instruments leading to increased demand for training sessions to educate technical staff regarding handling and usage. In addition, factors such as frequent software updates and improved services offered by market players to remain competent are driving the segment growth. 

Regional Insights

North America accounted for the largest revenue share in 2016. Major drivers include the high adoption of advanced techniques and diagnostic tools, higher healthcare expenditure, and availability of skilled professionals. The U.S. holds the largest market share owing to factors such as highly developed healthcare infrastructure and the availability of skilled professionals. Moreover, the high adoption of personalized medicines, stem cell therapies, and soft tissue transplants are augmenting the regional market growth.

On the contrary, regulations such as the Organ Transplantation Act that imposes restrictions on reimbursement policies for organ donors is negatively affecting the market. The existing demand and supply gap in organ donation and the availability of alternatives for heart and liver transplants is restraining the market growth.

Transplant Diagnostics Market Share Insights

The global market is highly competitive with very few players competing with each other in the international market. The quality and accuracy constraints of transplant diagnostic techniques like serology-based and PCR-based HLA typing increase the overall cost of products. As a result, players are implementing strategies, such as long-term contracts with diagnostic clinics and laboratories and discount pricing for bulk purchases.

Major market players include Thermo Fisher Scientific, Inc.; Illumina, Inc.; F. Hoffmann La-Roche AG.; Abbott Laboratories, Inc.; Qiagen N.V.; Immucor Transplant Diagnostics, Inc.; Bio-rad Laboratories, Inc.; Affymetrix, Inc.; and Omixon Ltd.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2015

Forecast period

2017 - 2024

Market representation

Revenue in USD Million & CAGR from 2017 to 2024

Regional scope

North America, Europe, Asia Pacific, Latin America & MEA

Country scope

The U.S., Canada, The U.K., Germany, China, India, Brazil, Mexico, & South Africa

Report coverage

Revenue, company share, competitive landscape, growth factors, trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2014 to 2024. For the purpose of this study, Grand View Research has segmented the global transplant diagnostics market report on the basis of technology, product, and region:

  • Technology Type Outlook (Revenue, USD Million, 2014 - 2024)

    • Molecular Assay

      • PCR-based Molecular Assay

      • Sequencing-based Molecular Assay

    • Non-molecular Assay

      • Serological Assay

      • Mixed Lymphocyte Culture Assay

  • Product Type Outlook (Revenue, USD Million, 2014 - 2024)

    • Reagents & Consumables

    • Instruments

    • Software and Services

  • Regional Outlook (Revenue, USD Million, 2014 - 2024)

    • North America

      • The U.S.

      • Canada

    • Europe

      • Germany

      • The U.K.

    • Asia Pacific

      • Japan

      • India

    • Latin America

      • Mexico

      • Brazil

    • Middle East & Africa

      • South Africa

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.